Vontobel Asset Management Inc. Sells 17,778 Shares of Henry Schein, Inc. (HSIC)
Vontobel Asset Management Inc. decreased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 15.2% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 99,315 shares of the company’s stock after selling 17,778 shares during the period. Vontobel Asset Management Inc. owned 0.13% of Henry Schein worth $18,175,000 as of its most recent filing with the SEC.
Other hedge funds also recently bought and sold shares of the company. SpiderRock Advisors LLC bought a new stake in Henry Schein during the first quarter worth $102,000. JNBA Financial Advisors bought a new stake in Henry Schein during the first quarter worth $170,000. Westside Investment Management Inc. bought a new stake in Henry Schein during the first quarter worth $168,000. Peddock Capital Advisors LLC boosted its stake in Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock worth $186,000 after buying an additional 247 shares during the last quarter. Finally, Van ECK Associates Corp boosted its stake in Henry Schein by 5.7% in the first quarter. Van ECK Associates Corp now owns 1,138 shares of the company’s stock worth $193,000 after buying an additional 61 shares during the last quarter. 90.73% of the stock is owned by institutional investors.
Henry Schein, Inc. (NASDAQ HSIC) traded up 1.11% during trading on Wednesday, reaching $182.68. The company had a trading volume of 17,249 shares. The firm has a market capitalization of $14.49 billion, a P/E ratio of 27.76 and a beta of 1.09. The company has a 50-day moving average of $182.32 and a 200-day moving average of $169.72. Henry Schein, Inc. has a 52-week low of $146.23 and a 52-week high of $186.99.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, May 9th. The company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.65 by $0.11. The firm had revenue of $2.92 billion during the quarter, compared to the consensus estimate of $2.83 billion. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.41 earnings per share. Analysts expect that Henry Schein, Inc. will post $7.28 EPS for the current fiscal year.
A number of equities analysts have recently issued reports on HSIC shares. Stifel Nicolaus reissued a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. Piper Jaffray Companies started coverage on Henry Schein in a research note on Monday, June 12th. They set a “neutral” rating and a $200.00 target price for the company. Barrington Research increased their target price on Henry Schein from $196.00 to $198.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 10th. Finally, Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, May 31st. Ten equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Henry Schein presently has an average rating of “Hold” and a consensus target price of $184.08.
In other Henry Schein news, EVP Gerald A. Benjamin sold 12,578 shares of the company’s stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $175.10, for a total value of $2,202,407.80. Following the completion of the sale, the executive vice president now directly owns 44,061 shares in the company, valued at $7,715,081.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.27% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.